Literature DB >> 12531056

Childhood tuberculosis: treatment strategies and recent advances.

J R Starke1.   

Abstract

Over the past 20 years, several major studies have shown that 6-month therapy, initially using isoniazid, rifampin and pyrazinamide, is highly effective and extremely safe for the treatment of most forms of childhood tuberculosis. The various drug schedules and frequency of administration will be reviewed. Directly observed therapy is an essential component of a paediatric tuberculosis treatment plan, though using it does not solve all problems with adherence to treatment. As the rates of drug-resistant tuberculosis increase around the world, special aspects of paediatric tuberculosis will have to be considered when designing treatment regimens for children. Finally, the next frontier of antituberculosis therapy may be the manipulation of the host immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12531056     DOI: 10.1053/prrv.2001.0117

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  3 in total

Review 1.  Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.

Authors:  Chrysanthi L Skevaki; Dimitrios A Kafetzis
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Epidemiology of smear - negative tuberculosis in ibadan, Nigeria.

Authors:  Oludiran Kehinde Aderemi; Hannah Dada-Adegbola
Journal:  Afr J Infect Dis       Date:  2013

3.  Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.

Authors:  Mercedes C Becerra; Soumya Swaminathan
Journal:  J Public Health Policy       Date:  2014-09-11       Impact factor: 2.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.